Thrombosis
Conference Coverage
How hemophilia B impacts education, work
ORLANDO—Even mild or moderate hemophilia B can have a negative impact on the education and careers of patients, according to the B-HERO-S study....
Conference Coverage
mAb could change treatment of hemophilia A, doc says
Photo by Linda Bartlett ORLANDO—Emicizumab, a bispecific monoclonal antibody (mAb), could potentially change the treatment paradigm of hemophilia...
Conference Coverage
Therapy seems safe, effective in kids with hemophilia
Photo courtesy of Baxalta ORLANDO—Results of a phase 3 study suggest the full-length recombinant factor VIII therapy Adynovate (BAX 855) can be...
Conference Coverage
Patients can safely receive less FVIII, study suggests
ORLANDO—It may be possible for hemophilia patients to receive less factor VIII (FVIII) without increasing their risk of bleeding, according to a...
News
TV time linked to risk of death from PE
Photo courtesy of LG The amount of TV a person watches each day may influence his risk of dying from pulmonary embolism (PE), according to...
News
CHMP recommends enoxaparin biosimilars
Image by Andre E.X.
News
Blood disorders prove costly for European economy
chemotherapy Photo by Rhoda Baer Malignant and non-malignant blood disorders cost 31 European countries a total of €23 billion in 2012, according...
News
Gene therapy granted breakthrough designation for hemophilia B
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to SPK-9001 for the treatment of hemophilia B. SPK-9001 is...
News
Early VTE prophylaxis better for sTBI, team says
Results of an observational study support early initiation of venous thromboembolism (VTE) prophylaxis in patients with severe traumatic brain...
News
COMP recommends orphan status for drug to treat PNH
The European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has issued a positive opinion recommending orphan designation for...
News
INR monitoring systems to be pulled from market
The Alere INRatio® and INRatio®2 PT/INR Monitoring Systems are being withdrawn from the US market because they may provide inaccurate...